Skip to main content
Account

Peer review reports

From: Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) – protocol for prospective cohort study

Original Submission
10 Jan 2020 Submitted Original manuscript
20 May 2020 Author responded Author comments - Delia Bogdanet
Resubmission - Version 2
20 May 2020 Submitted Manuscript version 2
6 Jun 2020 Author responded Author comments - Delia Bogdanet
Resubmission - Version 3
6 Jun 2020 Submitted Manuscript version 3
13 Jun 2020 Author responded Author comments - Delia Bogdanet
Resubmission - Version 4
13 Jun 2020 Submitted Manuscript version 4
Publishing
3 Jul 2020 Editorially accepted
18 Jul 2020 Article published 10.1186/s12884-020-03090-9

Learn about peer review

Back to article page

Navigation